Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Identify index funds with top risk-adjusted returns to guide smarter allocations. Learn criteria for selecting high-efficiency funds.
28,465 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
With inflation cooling and rates fluctuating, investors are turning to income-focused ETFs to create steady paychecks...
When criminals target banks with fake IDs, everyday savers can pay the price. This article unpacks what happened, how...
Cathie Wood and Ark Invest pulled cash from several holdings in a single session, sparking questions about risk, liqu...
A tech-heavy portfolio is getting a diversification push as AVUV draws new attention among 38-year-olds with $500k sa...
KBR has endured a tough year, with the stock fallen this past year by about 45%. A fresh stake worth $24 million from...
The Fed has stopped cutting rates, but that doesn’t mean investors should abandon Realty Income. This article explain...
A prominent investor reduced its position in a leading sports tech stock, triggering a market rally of questions. Thi...
When stocks wobble, redirecting payouts to safer assets can cushion the blow. This article explains how dividends rei...
This comprehensive guide explains what frequent intraday trading is, who it suits, and how to manage risk with real-w...
Warren Buffett’s transition at Berkshire Hathaway puts Apple in the spotlight as the conglomerate’s largest public ho...
NVIDIA will begin counting stock-based compensation in non-GAAP results from Q1 FY2027, a shift that rekindles a long...